Literature DB >> 20300861

Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.

Zhi Song1, Ren Li, Nan You, Kaishan Tao, Kefeng Dou.   

Abstract

Analysis of loss of heterozygosity (LOH) is a useful method for finding genetic alterations in tumor and precancerous lesion tissues. In this study, we analyzed LOH of the tumor suppressor gene Tg737 in side population cells of human hepatocellular carcinomas. Side population cells were sorted and identification by flow cytometry from suspensions of hepatocarcinoma or normal liver cells generated from 95 hepatocellular carcinoma and normal tissues, respectively. DNA was extracted from the two groups of side population cells and peripheral blood specimens. Five microsatellite markers on the Tg737 gene were used to analyze the frequency of loss of heterozygosity in the side population cells of the hepatocellular carcinoma. Twenty-four (25.30%) tumor samples had a large deletion in more than three microsatellite markers. The highest frequency of loss of heterozygosity was observed with the G64212 marker (78.75%) and the SHGC-57879 marker (75.95%). Statistical analysis of the correlation between loss of heterozygosity of Tg737 and clinicopathological features indicated a strong correlation between the two markers associated with the highest frequency of loss of heterozygosity and survival. The results indicate that loss of heterozygosity of the tumor suppressor gene Tg737 may play an important role in the carcinogenetic mechanism of liver cancer stem cells. In addition, the independent association between loss of heterozygosity at the SHGC-57879 and G64212 markers and worsened short-term survival in patients could be used as a novel prognostic predictor. Further studies of side population cells may contribute to the establishment of novel therapeutic strategies for hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300861     DOI: 10.1007/s11033-010-0069-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  72 in total

1.  Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.

Authors:  Li-Sung Hsu; Hsin-Chen Lee; Gar-Yang Chau; Pen-Hui Yin; Chin-Wen Chi; Wing Yiu Lui
Journal:  Oncol Rep       Date:  2006-02       Impact factor: 3.906

2.  Cellular and molecular regulation of skeletal muscle side population cells.

Authors:  Annette P Meeson; Thomas J Hawke; Sarabeth Graham; Nan Jiang; Joel Elterman; Kelley Hutcheson; J Michael Dimaio; Teresa D Gallardo; Daniel J Garry
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Isolation and characterization of a stem cell population from adult human liver.

Authors:  Maria Beatriz Herrera; Stefania Bruno; Stefano Buttiglieri; Ciro Tetta; Stefano Gatti; Maria Chiara Deregibus; Benedetta Bussolati; Giovanni Camussi
Journal:  Stem Cells       Date:  2006-08-31       Impact factor: 6.277

4.  Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.

Authors:  Y W Lin; J C Sheu; L Y Liu; C H Chen; H S Lee; G T Huang; J T Wang; P H Lee; F J Lu
Journal:  Eur J Cancer       Date:  1999-11       Impact factor: 9.162

5.  Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma.

Authors:  Hashim Elmileik; Alan C Paterson; Michael C Kew
Journal:  J Surg Oncol       Date:  2005-09-15       Impact factor: 3.454

6.  Characterization of a side population of cancer cells from human gastrointestinal system.

Authors:  Naotsugu Haraguchi; Tohru Utsunomiya; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Graham F Barnard; Masaki Mori
Journal:  Stem Cells       Date:  2005-10-20       Impact factor: 6.277

7.  Oval cell proliferation associated with the murine insertional mutation TgN737Rpw.

Authors:  W G Richards; B K Yoder; R J Isfort; P G Detilleux; C Foster; N Neilsen; R P Woychik; J E Wilkinson
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

8.  Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.

Authors:  Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Terumasa Yamada; Hidewaki Nakagawa; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Yo Sasaki; Osamu Ishikawa; Shingi Imaoka; Morito Monden
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

9.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; T Sadamoto; G Isowa; K Honda; Y Yamaoka; M Ikenaga; H Imura; K Ishizaki
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

10.  Up-regulation of Tropomyosin related kinase B contributes to resistance to detachment-induced apoptosis in hepatoma multicellular aggregations.

Authors:  Zhiyong Zhang; Lihui Han; Yugang Liu; Xiaohong Liang; Wensheng Sun
Journal:  Mol Biol Rep       Date:  2008-07-02       Impact factor: 2.316

View more
  7 in total

1.  Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma.

Authors:  Yegui Jiang; Hucheng Gao; Mingdong Liu; Qing Mao
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

2.  Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer.

Authors:  Junguee Lee; Shinae Yi; Minho Won; Young Shin Song; Hyon-Seung Yi; Young Joo Park; Ki Cheol Park; Jung Tae Kim; Joon Young Chang; Min Joung Lee; Hae Joung Sul; Ji Eun Choi; Koon Soon Kim; Jukka Kero; Joon Kim; Minho Shong
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

3.  MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Authors:  Ge Zhao; Ting Wang; Qi-Ke Huang; Meng Pu; Wei Sun; Zhuo-Chao Zhang; Rui Ling; Kai-Shan Tao
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

Review 4.  Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.

Authors:  Wei-Hui Liu; Nan You; Ning Zhang; Hong-Tao Yan; Tao Wang; Zhu Huang; Hong-Bao Liu; Li-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2012-11-22       Impact factor: 6.730

5.  Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells.

Authors:  Nan You; Weihui Liu; Lijun Tang; Xiao Zhong; Ru Ji; Ning Zhang; Desheng Wang; Yong He; Kefeng Dou; Kaishan Tao
Journal:  J Exp Clin Cancer Res       Date:  2012-09-13

Review 6.  Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.

Authors:  Ru Wang; Xiao Li; Huimin Zhang; Ke Wang; Jianjun He
Journal:  Oncotarget       Date:  2017-09-01

7.  Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.

Authors:  Chun-Ping Wu; Liang Zhou; Ming Xie; Huai-Dong Du; Jie Tian; Shan Sun; Jin-Yan Li
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.